Liver stiffness at baseline as a marker of hepatocellular carcinoma in cirrhosis: A matched analysis

doi:10.4291/wjgp.v17.i2.120603

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

(36)

(31)

(0)

(293)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Pathophysiol. Jun 22, 2026; 17(2): 120603
Published online Jun 22, 2026. doi: 10.4291/wjgp.v17.i2.120603

Table 2 Baseline characteristics of hepatocellular carcinoma patients, n (%)/median (interquartile range)

Characteristics	Patients with HCC, n = 133
Duration	2.6 (1.2-3.0)
Presentation at time of diagnosis of HCC
Screening/incidental	37 (28.7)
Jaundice	42 (31.6)
Hepatic encephalopathy	8 (6.1)
Bleed	4 (3.1)
Ascites	14 (10.5)
BCLC grading (stage)
0	19 (14.7)
A	21 (16.3)
B	29 (17.8)
C	23 (17.8)
D	37 (28.7)
Treatment received
Resection	6 (4.5)
Liver transplant	7 (5.4)
Microwave ablation	18 (13.5)
SBRT	11 (8.3)
TACE	19 (14.3)
Tyrosine kinase inhibitors	34 (25.6)
Immunotherapy	5 (3.8)
Palliative therapy	29 (21.8)

BCLC: Barcelona-Clinic Liver Cancer; HCC: Hepatocellular carcinoma; SBRT: Stereotactic body radiation therapy; TACE: Transarterial chemoembolization.

Full Size Table

Citation: Mehta V, Goyal MK, Gupta YK, Gupta A, Khubber M, Sehgal T, Mehta P, Goyal O. Liver stiffness at baseline as a marker of hepatocellular carcinoma in cirrhosis: A matched analysis. World J Gastrointest Pathophysiol 2026; 17(2): 120603
URL: https://www.wjgnet.com/2150-5330/full/v17/i2/120603.htm
DOI: https://dx.doi.org/10.4291/wjgp.v17.i2.120603

Mehta V, Goyal MK, Gupta YK, Gupta A, Khubber M, Sehgal T, Mehta P, Goyal O. Liver stiffness at baseline as a marker of hepatocellular carcinoma in cirrhosis: A matched analysis. World J Gastrointest Pathophysiol 2026; 17(2): 120603 [PMID: 42394831 DOI: 10.4291/wjgp.v17.i2.120603]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.